ACCREDITATION AND CREDIT DESIGNATION
The Educational and Research Foundation for the American Academy of Facial Plastic and Reconstructive Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AAFPRS Foundation designates this live activity for 25.5 AMA PRA Category One Credits TM . Physicians should claim credit commensurate with the extent of their participation in the activity.
EVALUATION AND CME CREDITS
The AAFPRS Foundation's LEARN (Lifelong Educational and Research Network) allows you to capture meeting evaluation responses and award CME credits on line at www.aafprs-learn.org.
Please note that in order to access your personal LEARN account, you will need to know your AAFPRS log on ID and password. If you do not know your current AAFPRS ID and password, please see Karen Sloat at the registration area and she will provide you with the necessary information to complete your evaluation and claim your CME credits. Knowing this information ahead of time will avoid delay in obtaining your credits on-site.
LEARNING OBJECTIVES
At the conclusion of the general sessions, participants should be able to: 1. Compare and contrast surgical techniques and approaches across the national and international spectrum of facial plastic and reconstructive surgery. 2. Review and apply state of the art decision making tools when addressing surgical and non surgical dilemmas in patient care. 3. Assess new techniques and technologies that could advance the surgical and non-surgical care of your patients. 4. Develop or improve management plan for your new or existing practice that enhances both patient care and practice productivity. 5. Consider new research questions and/or collaborations. 6. Identify, avoid and treat complications, when necessary.
TARGET AUDIENCE
The meeting is offered for continuing medical education of medical students, residents, fellows, and practicing physicians (MDs and DOs) in the field of facial plastic and reconstructive surgery. The program is for physicians with all levels of experience and covers aesthetic, reconstructive, and congenital issues relevant to this specialty.
Disclaimer
Registrants for this course understand that medical and scientific knowledge is constantly evolving and that the views and techniques of the instructors are their own and may reflect innovations and opinions not universally shared. The views and techniques of the instructors are not necessarily those of the Academy or its Foundation but are presented in this forum to advance scientific and medical education. Registrants waive any claim against the Academy or its Foundation arising out of information presented in this course. Registrants also understand that operating rooms and health-care facilities present inherent dangers. Registrants waive any claim against the Academy or Foundation for injury or other damage resulting in any way from course participation. This educational program is not designed for certification purposes. Neither the AAFPRS nor its Foundation provides certification of proficiency for those attending. The AAFPRS Foundation would like to thank the following companies for their in-kind support to the 2017 AAFPRS Annual Meeting: Galderma Laboratories -disposable products Merz Aesthetics -disposable products Allergan -disposable products Thermi Aesthetics -disposable products Anthony Products/GioPelle -durable equipment Unless noted as off-site, all committee and Board meetings, educational sessions, exhibitions, and social events will be held at the Sheraton Grand Phoenix Hotel (the rooms are noted herein). All session rooms are on the second level of the hotel; registration and the Exhibit Hall are on the third level. At the completion of this activity, the participant will appreciate the purse string suture as a simple and reversible maneuver that can dramatically reduce defect size. 2. At the completion of this activity, the participant should know how to implement the purse string suture in the reconstruction of head and neck skin cancer defects and recognize its utility as an adjunct to the reconstructive ladder. Study Objective(s): To evaluate the utility of the purse string suture as an adjunct to the reconstructive ladder when reconstructing skin cancer defects of the head and neck. Design: Prospective non-randomized cohort study in a single tertiary academic medical center from January 2016 -June 2016.
WEDNESDAY, OCTOBER
Method: This prospective non-randomized cohort included 109 consecutive adult patients with head and neck defects resulting from skin cancer resection. Patients were eligible if they were older than 18 years and able to give informed consent. Patients were excluded if defects required significant repair of deep tissue layers including muscle or bone. The purse string suture was placed in every patient following skin cancer resection. Patients were evaluated before and after suture placement and potential reconstructive methods were recorded. Results: The purse string suture resulted in a mean defect area reduction of 77.1% (p<0.001) in all patients, and was used in the final reconstruction in 79 (72.5%) patients. The vertex scalp was the only subsite with significantly less reduction in mean surface area (38.4%, p<0.001). After the purse string suture was placed, secondary intention healing and primary closure were used in 63% of patients compared to 30% based on pre-purse string suture assessment. Since that time, she has used an orbital implant. Over the past two years, the patient started having difficulties associated with volume loss and orbital contraction. Multiple dermal fat grafts were attempted without success. On exam, patient is status post right-sided enucleation with evidence of severe contraction of the orbit with foreshortened superior and inferior fornices. At the time of her visit, surgical plans were discussed and she agreed to proceed with reconstruction. She was taken to the operating room by both a facial reconstructive surgeon and an oculoplastic surgeon, and underwent a right-sided temporoparietal fascia flap based off the superficial temporal artery and vein. The flap was tunneled subcutaneously into the right orbit, which was then used for volume augmentation. Buccal mucosa was harvested and grafted to complete her lid reconstruction. She has been seen in the clinic postoperatively and reports satisfaction, both from a function and cosmetic standpoint. Conclusion: Orbital reconstruction remains a challenge for even the most gifted head and neck surgeons. In this article, we describe the challenges associated with such a reconstruction, as well as the successful implementation of a temporoparietal fascia flap to reconstruct an orbital and lid defect. Among the respondents, 72.4% were male (n=155) with a mean age of 41 years old. Forty-two percent of the participants were residents (n=90), whereas 47.7% were fellowship-trained (n=102). Within the cohort, 23 surgeons indicated they routinely performed microvascular reconstruction. Ten of these surgeons endorsed associated musculoskeletal symptoms, with 50% of them experiencing symptoms as early as residency and fellowship (n=5) and the majority of the symptoms occurring half of the time or during most surgery cases (n=6). The neck and shoulders were the most commonly affected muscle groups. Eightytwo participants responded that they performed other non-specific surgical procedures; the majority indicated they experienced musculoskeletal symptoms (n=51), with 18 surgeons symptomatic as early as during residency and fellowship. The neck, shoulder, and back were the most frequently affected muscle groups. Among symptomatic respondents, 58.0% sought therapy (13 respondents required surgery) for their symptoms. Sixty-six percent of participants (n=41) reported no training in ergonomics principles in residency or fellowship, whereas only 24.3% have sought out specific information regarding ergonomic principles in surgery (n=52). This data comes from a larger study that surveyed otolaryngologists across all subspecialties and was presented for another national otolaryngologic organization at the 2017 Combined Otolaryngology Spring Meeting. However, the survey responses from facial plastic surgeons have never been previously analyzed and presented separately. Conclusion: Awareness of surgical ergonomics principles among facial plastic surgeons is limited. Although musculoskeletal issues appear to be common, few surgeons seek treatment or information about ergonomics. Further knowledge of the ergonomic burden of the subspecialty profession is beneficial and will yield insight on how to both relieve the physical stress and improve the career span of a facial plastic surgeon. Results: The muscle was better appreciated with the injected green Ultrasound Gel. There was good uptake and the muscle could be clearly delineated. The red colored ultrasound gel had the least impression on the muscle, as it tends to blend in to its natural color while the yellow colored ultrasound gel gives a weak delineation of the muscular plane. The blue color has a crude impression as it has a smudging effect on the muscular and surrounding planes. Conclusion: Ultrasound gel has good diffusion in muscle. Ample visualization of the muscle using green ultrasound gel will provide better knowledge as to where the correct plane for neurotoxin injection is. The limitation of this study is that colors were limited to the primary ones. It is encouraged that further investigation of mixture of colors as well as documented trials in cadavers should be done. Design: Non-randomized, controlled clinical trial Method: 45 healthy women age 25-80 were included in this study. Treatment of the face with an FDA-approved RF/ PEMF device was performed on a weekly basis for a total of 8 weeks. Skin elasticity was measured using a Cutometer prior to start of the treatment protocol, again at week 8, and 12 weeks after the last treatment. Pre-and post-treatment protocol photographs were taken, and improvement in skin appearance was rated using the Fitzpatrick Wrinkle & Elastosis Scale (FWES) by a blinded facial plastic surgeon. Patient-reported outcomes were determined using a Global Aesthetic Improvement Scale (GAIS) and Subject Satisfaction Scale.
Results: There was no statistically significant difference in Cutometer measurements after treatment with the RF/PEMF device at 8 weeks and 20 weeks. However, there was a statistically significant improvement in FWES as determined by the blinded rater using pre-and post-treatment photographs. Patients also reported subjective improvement, and were generally satisfied with the treatment. Conclusion: Although there was no numerical improvement in skin elasticity as measured by the Cutometer, RF/PEMF treatment can improve subjective skin appearance. Further study is needed to determine long term effects, however this regimen is a noninvasive alternative for patients interested in aesthetic improvement. To assess the effectiveness of a replantation of near complete nasal amputation Design: Case report Method: Near complete nasal amputation in a 26M at a university medical center was identified. He sustained partial avulsion of the right lateral nasal wall, complete avulsion of the nasal tip with a horizontal laceration through the tip, near complete avulsion of the right ala, partial avulsion of the left ala and partial amputation of the columella after he was hit in the face with a metal pole. The flap remained partially attached by the columellar pedicle, which itself sustained a superficial laceration. On presentation to the ER, the avulsed flap was noted to be hyperemic and bleeding at the skin edges and so we decided to preserve the flap. 1% lidocaine without epinephrine was used for analgesia, and he was given Unasyn and a tetanus vaccine. The columellar and nasal tip lacerations was repaired first to stabilize the flap's blood supply. The flap was then reattached with 5-0 vicryl and 5-0 prolene. 5-0 chromic was used to repair the mucosal defects. After the repair was completed, venous congestion was noted, however, no intervention was performed since loosely approximated sutures were used for the mucosal closure to allow for outflow. Antibiotics were continued. Results: On postoperative day 3 the flap was mildly hyperemic, but was noted to have good capillary refill. The sutures were removed on postoperative day 6. He had significant crusting but no wound breakdown. Design: This was a prospective, within-subject-controlled, double-blind study. Method: Adults (N=123) were randomized to initial/touchup treatment with Vollure XC in 1 NLF and control (Restylane-L) in the contralateral NLF. Co-primary effectiveness endpoints at month 6 were difference in improvement in mean NLF Severity Scale (NLFSS) score for Vollure XC versus control and NLFSS responder rate (e"1-point improvement vs baseline) for Vollure XC. Other effectiveness endpoints for Vollure XC included subjectassessed Appraisal of Nasolabial Folds (FACE-Q) and investigator-assessed smoothness and natural look. Subjects reported injection site responses (ISRs). Results: Co-primary effectiveness endpoints were met. Vollure XC was non-inferior to control (NLFSS scores improved by 1.4 with Vollure XC and 1.3 with control) and responder rates with Vollure XC were 93% at 1, 3, and 6 months. The median volume of initial/touch-up was 1.7 mL for both products. Mean FACE-Q score for Vollure XC was e"70 at months 3 and 6 versus 32 at baseline, indicating improvement. When one NLF was rated smoother than the other, the majority (71%) of smoother NLFs had been treated with Vollure XC. From day 3 to month 6, a difference in the natural look of each NLF region was reported in 77%-85% of subjects, with Vollure XC providing a more natural look in twice as many cases as control at all timepoints. Fewer severe ISRs were reported with Vollure XC vs control, particularly firmness (19%, 43%), swelling (17%, 43%), tenderness to touch (17%, 34%), and lumps/bumps (14%, 39%). Conclusion: Vollure XC demonstrating effectiveness for correcting moderate to severe NLFs in 93% of subjects at the primary time point and was safe and well tolerated. The objective of this presentation is to educate the audience on the anatomy and utility of the PLLAN flap (which we have not found described elsewhere) for reconstruction of full-thickness nasal defects as a viable alternative to the paramedian forehead flap. Design: Anatomical cadaver study, review of literature, and demonstration of clinical examples of use of our flap. Method: Anatomic dissections of fresh cadaveric specimens, search of PubMed and MeSh database using keywords nasal reconstruction, paramedian forehead flap, levator labii superioris alaquae nasi, and reconstruction of facial defects as well as clinical examples of patients in whom we have used our flap for reconstruction Results: From the anatomic dissections, we have determined average distances to the vascular pedicle from the nasal sill and ala. We also examine the typical anatomic relationship of the pedicle and muscle to the orbicularis oris muscle and origin of the pedicle from the superior labial artery and vein, all of which will assist surgeons in utilizing this flap for nasal reconstruction. We also provide a review of relevant literature in the area of reconstruction of facial defects as a background for our discussion. Conclusion: The Pedicled Levator Labii superioris Alaquae Nasi flap is a highly versatile tool for reconstruction of nasal defects, including full-thickness defects. The flap is simple to harvest and can be created in a variety of sizes and shapes. The muscle itself is suitable for use as the internal lining of full-thickness nasal defects due to the fact that the muscle mucosalizes over time, obviating the need for mucosal hinge flaps. It has significantly less physical and psychological morbidity than the paramedian forehead flap and serves as a single-stage option for reconstruction. The radial forearm free flap (RFFF) has become a frequently utilized option in the reconstruction of head and neck defects given its versatility and minimal morbidity. The neurovascular anatomy of the forearm led to the description of the sensate RFFF. The purpose of this article was to review the literature that has illustrated the neurosome of the lateral antebrachial cutaneous nerve (LACN). Design: Systematic review. Method: The terms radial forearm free flap, lateral antebrachial cutaneous nerve, neurosome, and sensate flap were searched on PubMed and Web of Science. Results: Anatomic and physiologic studies have found the LACN to be distributed along the radial aspect of the forearm. Conclusion: When the decision is made to harvest a sensate RFFF, centering the flap over the radial aspect of forearm will allow for greatest capture of the LACN neurosome. This study included all patients undergoing transcutaneous lower blepharoplasty with SOOF lift by the senior author at an outpatient private facial plastic surgery center. At the end of the procedure, a total of 12 mg of triamcinolone acetonide 40mg/mL (6 mg on each side) was injected under the skin muscle flaps bilaterally for 28 patients who underwent surgery after July 1, 2016. This was compared with 28 consecutive patients who underwent the procedure prior to the intervention. Patients were followed for 3 months after surgery to determine the presence of lower lid retraction requiring intervention, including postoperative triamcinolone injection or revision surgery. Wound healing concerns and complaints about scars were also recorded.
Results: There was a statistically significant decrease in the number of patients experiencing post-operative lower lid retraction requiring post-operative triamcinolone injection (p<0.009). There were no patients requiring revision surgery either before or after the intervention. There were no problems with healing after the intervention and actually a non-statistically significant decrease in complaints of post-operative scaring in patients receiving intraoperative triamcinolone. Conclusion: Intraoperative triamcinolone injection significantly decreases the rate of post-operative lower lid retraction after transcutaneous lower lid blepharoplasty with SOOF lift. There were no negative effects on wound healing. Learners should be able to both dentify patients that would benefit from reconstruction with Integra (TM) Wound Matrix, and become familiar enough with the technique to execute it in their practice. Study Objective(s): Nasal reconstruction poses many challenges to the reconstructive surgeon. By integrating the use of Integra (TM) Wound Matrix into our technique repertoire, we have described a novel technique in a large population of patients requiring reconstruction of nasal defects. This technique has yielded an excellent option for patients with partial thickness nasal defects with wound beds unsuitable for skin grafts or local flaps. This technique is particularly useful when resurfacing partial thickness nasal defects over exposed bone, cartilage, or autologous structural grafts. This technique frequently spares a patient a larger reconstructive procedure such as a regional flap, with excellent aesthetic results.
Design: This is a prospective case series performed on participating patients presenting with nasal defects requiring reconstruction. Method: Patients presenting to the Facial Plastics Department at Vanderbilt University Medical Center after Mohs micrographic excision of the nose. Patients were offered reconstruction with Integra(TM) Wound Matrix if they presented with partial thickness nasal defects with exposed cartilage or bone in the wound bed, a large area requiring resurfacing, a wound requiring structural grafting, or a defect otherwise indicating reconstruction with a regional flap (paramedian or melolabial) in a poor or unwilling candidate. Reconstruction was performed by first optimizing the wound bed by completing subunit excision, undermining skin edges, and placing any necessary structural cartilage grafts. Integra(TM) was then placed in the wound bed and bolstered in place. The first step in translation was to produce two independent forward translations into the target language. Two translators, both native Spanish speakers and fluent in English, independently produced a forward translation of the VELO assessment. The two translations were then reconciled into a single translation, the first version of the Spanish VELO. Backward translation: The reconciled translation was then translated back into English by a third translator. This translator had no previous access to the original English VELO, and was also both a native Spanish speaker and fluent in English. This backward translation and the original English VELO were compared by the research team to find any translation discrepancies or incorrect translations. This resulted in changes to the first reconciled Spanish version and gave rise to a second version of the Spanish VELO. Cognitive Interviewing: The second version of the Spanish VELO was administered to a panel of respondents using cognitive interview techniques. The participants included Spanish speaking parents of children with VPI as well as children over 8 years old with a history of VPI. These parents were interviewed as a group by study staff. During the interview, parents were asked to discuss the Spanish VELO assessment, interpret all items, and provide possible alternatives for confusing translations. Results: The main purpose of this process was to ensure that there are no significant cultural gaps in the finalized Spanish VELO translation. The translation process and back translations identified 5 word choice and phrase corrections, while the rigid cognitive interview process with patient families encountered 4 VELO -Spanish instrument items for clarification and restructuring. Through these efforts, the Spanish VELO is both comprehensible and cognitively equivalent to the English language VELO instrument. Conclusion: The linguistic validation process resulted in a up treatment and subject satisfaction on an 11-point scale (0=completely dissatisfied; 10=completely satisfied) through month 18 after initial/touch-up treatment and at 1 month after repeat treatment. Injection site responses (ISRs) were assessed. Results: After initial/touchup treatment, Vollure XC responder rates were 93% at months 1, 3, and 6, 85% at month 9, decreased to 59% at month 18, and increased to 94% at 1 month after repeat treatment. Improvement in mean FACE-Q scores over 18 months versus baseline showed continued benefit of Vollure XC from the subject perspective; at months 3, 6, 12, and 18, FACE-Q scores were 70, 73, 58, and 50, respectively, versus baseline score of 32. Subjects reported a high level of satisfaction with Vollure XC throughout the study, with 82% of subjects very satisfied with treatment at month 6, 76% at month 12, 68% at month 18, and 94% at 1 month after repeat treatment. The appeal of hyaluronic acid (HA) dermal fillers for facial soft tissue augmentation is attributed to both the immediate aesthetic effect and the relatively short recovery time involved. This study evaluated the duration (in hours) until subjects felt comfortable with a return to social engagement following correction of nasolabial folds (NLFs) using either of 2 select HA filler products, HA-RR and HA-RD, formulated with XpresHAn TechnologyTM.
Design: This was a 1-month, open label, single-center, noncomparative study to evaluate the duration (in hours) until subjects felt comfortable with a return to social engagement (RTSE) following correction of NLFs. Method: Twenty subjects with moderate or severe bilateral NLFs were treated with HA-RR or HA-RD. Subjects maintained a 14-day diary documenting recovery time. Posttreatment assessments included total hours to RTSE, investigator-assessed NLF improvement by Wrinkle Severity Rating Scale (WSRS) at day 14 and 30, investigator-and subject-assessed improvement by Global Aesthetic Improvement Scale (GAIS) at day 30, subject satisfaction, safety, and injection related events (IREs) at day 14 and 30.
Results: Fifty percent of subjects reported RTSE within 2 hours posttreatment, which increased to 90% by the 3rd day (evening) posttreatment. WSRS and GAIS improved significantly at all posttreatment evaluations, and subject satisfaction was high. The majority of subjects reporting RTSE within 24 hours were treated for moderate NLFs or with 2 mL (or less) of product. The majority of IREs were mild or moderate. Conclusion: Treatment of moderate-to-severe NLFs with HA-RR or HA-RD can involve minimal recovery time (ie, RTSE within same day as treatment) for some patients, and provides a high degree of clinician and subject satisfaction. Treatment with HA-RR or HA-RD also provides a natural looking aesthetic outcome and was found to be safe and well tolerated. To describe the creation of a temporary nasal prosthesis that can be used to cover and dress nasal defects after cancer excision. To describe a temporary prosthesis that allows the patient to care more easily for a nasal wound and conceal the nasal defect while in public Study Objective(s): To describe the creation of a temporary, inexpensive, defect-specific nasal prosthesis that can be utilized after nasal skin cancer excision Design: Case Report Method: We describe a case of a 97 year old patient who underwent staged, wide local excision of an aggressive basal cell carcinoma on the dorsum of the nose. The excision resulted in a through and through defect involving the upper and middle third of her nose. Due to uncertainty of margin clearance, a secondary reconstruction was planned. The location of the defect makes it challenging to dress the region. We describe the creation of a defect specific temporary prosthetic utilizing Aquaplast ® Thermoplast and disposable eye shields. Results: The patient-specific temporary prosthesis allows for ease of care of the nasal wound in the post-operative setting while pending definitive reconstruction. Furthermore, it does not irritate the eyes, nor does it limit vision, a common occurrence with various other dressing types. Conclusion: The novel use of a patient-customized temporary nasal prosthesis should be added to the tools available to the reconstructive surgeon for addressing this common defect.
